Guangzhou Wondfo Biotech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 23.76%

Guangzhou Wondfo Biotech Co Ltd (300482) has an Asset Resilience Ratio of 23.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Guangzhou Wondfo Biotech Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.60 Billion
≈ $234.11 Million USD Cash + Short-term Investments

Total Assets

CN¥6.73 Billion
≈ $985.42 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Guangzhou Wondfo Biotech Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guangzhou Wondfo Biotech Co Ltd balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Wondfo Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300482 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.60 Billion 23.76%
Total Liquid Assets CN¥1.60 Billion 23.76%

Asset Resilience Insights

  • Good Liquidity Position: Guangzhou Wondfo Biotech Co Ltd maintains a healthy 23.76% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou Wondfo Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Wondfo Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for Guangzhou Wondfo Biotech Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Wondfo Biotech Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 19.15% CN¥1.26 Billion
≈ $185.03 Million
CN¥6.60 Billion
≈ $966.03 Million
+0.90pp
2024-12-31 18.26% CN¥1.31 Billion
≈ $191.15 Million
CN¥7.15 Billion
≈ $1.05 Billion
+5.74pp
2023-12-31 12.52% CN¥722.45 Million
≈ $105.72 Million
CN¥5.77 Billion
≈ $844.58 Million
-2.37pp
2022-12-31 14.89% CN¥938.07 Million
≈ $137.27 Million
CN¥6.30 Billion
≈ $922.05 Million
+3.09pp
2021-12-31 11.79% CN¥572.73 Million
≈ $83.81 Million
CN¥4.86 Billion
≈ $710.56 Million
+9.41pp
2020-12-31 2.38% CN¥102.60 Million
≈ $15.01 Million
CN¥4.31 Billion
≈ $630.12 Million
-1.00pp
2019-12-31 3.38% CN¥99.50 Million
≈ $14.56 Million
CN¥2.94 Billion
≈ $430.80 Million
+4.04pp
2018-12-31 -0.66% CN¥-17.66 Million
≈ $-2.58 Million
CN¥2.69 Billion
≈ $393.85 Million
+2.28pp
2017-12-31 -2.94% CN¥-49.75 Million
≈ $-7.28 Million
CN¥1.69 Billion
≈ $248.00 Million
-2.93pp
2016-12-31 -0.01% CN¥-69.38K
≈ $-10.15K
CN¥1.01 Billion
≈ $147.17 Million
+0.00pp
2015-12-31 -0.01% CN¥-60.83K
≈ $-8.90K
CN¥798.57 Million
≈ $116.86 Million
--
pp = percentage points

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices
Market Cap
$1.09 Billion
CN¥7.42 Billion CNY
Market Cap Rank
#8575 Global
#2044 in China
Share Price
CN¥15.86
Change (1 day)
+0.57%
52-Week Range
CN¥15.55 - CN¥25.56
All Time High
CN¥92.01
About

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rhe… Read more